-
1
-
-
79952122979
-
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute leukemia: The JALSG AML201 Study
-
Ohtake S, Miyawaki S, Fujita H, Kiyoi H, Shinagawa K, Usui N, Okumura H, Miyamura K, Nakaseko C, Miyazaki Y, Fujieda A, Nagai T, Yamane T, Taniwaki M, Takahashi M, Yagasaki F, Kimura Y, Asou N, Sakamaki H, Handa H, Honda S, Ohnishi K, Naoe T, Ohno R. Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute leukemia: the JALSG AML201 Study. Blood. 2011;117:2358-65.
-
(2011)
Blood
, vol.117
, pp. 2358-2365
-
-
Ohtake, S.1
Miyawaki, S.2
Fujita, H.3
Kiyoi, H.4
Shinagawa, K.5
Usui, N.6
Okumura, H.7
Miyamura, K.8
Nakaseko, C.9
Miyazaki, Y.10
Fujieda, A.11
Nagai, T.12
Yamane, T.13
Taniwaki, M.14
Takahashi, M.15
Yagasaki, F.16
Kimura, Y.17
Asou, N.18
Sakamaki, H.19
Handa, H.20
Honda, S.21
Ohnishi, K.22
Naoe, T.23
Ohno, R.24
more..
-
2
-
-
29244475038
-
The treatment of AML: Current status and novel approaches
-
Burnett AK. The treatment of AML: current status and novel approaches. Hematology. 2005;10(Suppl 1):50-3.
-
(2005)
Hematology
, vol.10
, Issue.SUPPL. 1
, pp. 50-53
-
-
Burnett, A.K.1
-
3
-
-
0033619959
-
Underrepresentation of patients 65 years of age or older in cancer - Treatment trials
-
Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer- treatment trials. N Engl J Med. 1999;341:2061-7.
-
(1999)
N Engl J Med
, vol.341
, pp. 2061-2067
-
-
Hutchins, L.F.1
Unger, J.M.2
Crowley, J.J.3
Coltman, C.A.4
Albain, K.S.5
-
4
-
-
0032939412
-
A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: Karyotypic features in relation to morphology, age and gender
-
Mauritzson N, Johansson B, Albin M, Billstrom R, Ahlgren T, Mikoczy Z, et al. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol. 1999;62:95-102.
-
(1999)
Eur J Haematol
, vol.62
, pp. 95-102
-
-
Mauritzson, N.1
Johansson, B.2
Albin, M.3
Billstrom, R.4
Ahlgren, T.5
Mikoczy, Z.6
-
5
-
-
66149148673
-
Age and acute myeloid leukemia: Real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
-
Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113:4179-87.
-
(2009)
Blood
, vol.113
, pp. 4179-4187
-
-
Juliusson, G.1
Antunovic, P.2
Derolf, A.3
Lehmann, S.4
Mollgard, L.5
Stockelberg, D.6
-
6
-
-
0028925154
-
De novo acute myeloid leukaemia in patients over 55-yearsold: A population-based study of incidence, treatment and outcome
-
Northern Region Haematology Group
-
Taylor PR, Reid MM, Stark AN, Bown N, Hamilton PJ, Proctor SJ. De novo acute myeloid leukaemia in patients over 55-yearsold: a population-based study of incidence, treatment and outcome. Northern Region Haematology Group. Leukemia. 1995;9: 231-7.
-
(1995)
Leukemia
, vol.9
, pp. 231-237
-
-
Taylor, P.R.1
Reid, M.M.2
Stark, A.N.3
Bown, N.4
Hamilton, P.J.5
Proctor, S.J.6
-
7
-
-
68949207957
-
The incidence of and mortality from leukaemias in the UK: A general population-based study
-
Bhayat F, Das-Gupta E, Smith C, McKeever T, Hubbard R. The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer. 2009;9:252.
-
(2009)
BMC Cancer
, vol.9
, pp. 252
-
-
Bhayat, F.1
Das-Gupta, E.2
Smith, C.3
McKeever, T.4
Hubbard, R.5
-
8
-
-
33750020532
-
The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England
-
Phekoo KJ, Richards MA, Moller H, Schey SA. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica. 2006;91:1400-4.
-
(2006)
Haematologica
, vol.91
, pp. 1400-1404
-
-
Phekoo, K.J.1
Richards, M.A.2
Moller, H.3
Schey, S.A.4
-
9
-
-
42149096533
-
Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century
-
Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica. 2008;93:594-600.
-
(2008)
Haematologica
, vol.93
, pp. 594-600
-
-
Pulte, D.1
Gondos, A.2
Brenner, H.3
-
10
-
-
0033984685
-
Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: A comparative study of Australian and Japanese adult cases
-
Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K, et al. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia. 2000;14:163-8.
-
(2000)
Leukemia
, vol.14
, pp. 163-168
-
-
Nakase, K.1
Bradstock, K.2
Sartor, M.3
Gottlieb, D.4
Byth, K.5
Kita, K.6
-
11
-
-
84874022967
-
-
NCCN, Accessed Aug 28 2010
-
NCCN. Guideline. http://www.nccn.org/professionals/physician-gls/f- guidelines.asp. Accessed Aug 28 2010.
-
Guideline.
-
-
-
12
-
-
84863756326
-
-
BCSH, Accessed Aug 28 2010
-
BCSH. Guidelines. http://www.bcshguidelines.com/guidelinesMENU.asp. Accessed Aug 28 2010.
-
Guidelines
-
-
-
13
-
-
0032188805
-
The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
-
The Medical Research Council Adult and Children's Leukaemia Working Parties
-
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92:2322-33.
-
(1998)
Blood
, vol.92
, pp. 2322-2333
-
-
Grimwade, D.1
Walker, H.2
Oliver, F.3
Wheatley, K.4
Harrison, C.5
Harrison, G.6
-
14
-
-
0034672269
-
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study
-
Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood. 2000;96:4075-83.
-
(2000)
Blood
, vol.96
, pp. 4075-4083
-
-
Slovak, M.L.1
Kopecky, K.J.2
Cassileth, P.A.3
Harrington, D.H.4
Theil, K.S.5
Mohamed, A.6
-
15
-
-
0037114753
-
Pretreatment cytogenetic abnormalities are predictive of induction success cumulative incidence of relapse and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461)
-
Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100:4325-36.
-
(2002)
Blood
, vol.100
, pp. 4325-4336
-
-
Byrd, J.C.1
Mrozek, K.2
Dodge, R.K.3
Carroll, A.J.4
Edwards, C.G.5
Arthur, D.C.6
-
17
-
-
70449647008
-
Proportional hazard tests and diagnostic based on weighted residuals
-
Grambsch PTT. Proportional hazard tests and diagnostic based on weighted residuals. Biometrika. 1994;81:515-26.
-
(1994)
Biometrika
, vol.81
, pp. 515-526
-
-
Grambsch, P.T.T.1
-
19
-
-
0031961755
-
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
-
Japan Adult Leukemia Study Group
-
Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, et al. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol. 1998;16:78-85.
-
(1998)
J Clin Oncol
, vol.16
, pp. 78-85
-
-
Asou, N.1
Adachi, K.2
Tamura, J.3
Kanamaru, A.4
Kageyama, S.5
Hiraoka, A.6
-
20
-
-
9444297295
-
All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia
-
Sanz MA, Vellenga E, Rayon C, Diaz-Mediavilla J, Rivas C, Amutio E, et al. All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood. 2004;104:3490-3.
-
(2004)
Blood
, vol.104
, pp. 3490-3493
-
-
Sanz, M.A.1
Vellenga, E.2
Rayon, C.3
Diaz-Mediavilla, J.4
Rivas, C.5
Amutio, E.6
-
21
-
-
33646404606
-
Age and acute myeloid leukemia
-
Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481-5.
-
(2006)
Blood
, vol.107
, pp. 3481-3485
-
-
Appelbaum, F.R.1
Gundacker, H.2
Head, D.R.3
Slovak, M.L.4
Willman, C.L.5
Godwin, J.E.6
-
22
-
-
0035469883
-
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
-
Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood. 2001;98: 1312-20.
-
(2001)
Blood
, vol.98
, pp. 1312-1320
-
-
Grimwade, D.1
Walker, H.2
Harrison, G.3
Oliver, F.4
Chatters, S.5
Harrison, C.J.6
-
23
-
-
0035870690
-
Karyotype and age in acute myeloid leukemia
-
Moorman AV, Roman E, Willett EV, Dovey GJ, Cartwright RA, Morgan GJ. Karyotype and age in acute myeloid leukemia. Are they linked? Cancer Genet Cytogenet. 2001;126:155-61.
-
(2001)
Are They Linked? Cancer Genet Cytogenet
, vol.126
, pp. 155-161
-
-
Moorman, A.V.1
Roman, E.2
Willett, E.V.3
Dovey, G.J.4
Cartwright, R.A.5
Morgan, G.J.6
-
24
-
-
0035760320
-
Dependence of age-specific incidence of acute myeloid leukemia on karyotype
-
Schoch C, Kern W, Krawitz P, Dugas M, Schnittger S, Haferlach T, et al. Dependence of age-specific incidence of acute myeloid leukemia on karyotype. Blood. 2001;98:3500.
-
(2001)
Blood
, vol.98
, pp. 3500
-
-
Schoch, C.1
Kern, W.2
Krawitz, P.3
Dugas, M.4
Schnittger, S.5
Haferlach, T.6
-
25
-
-
0031893746
-
Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia
-
Ferrara F, Annunziata M, Copia C, Magrin S, Mele G, Mirto S. Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia. Haematologica. 1998;83:126-31.
-
(1998)
Haematologica
, vol.83
, pp. 126-131
-
-
Ferrara, F.1
Annunziata, M.2
Copia, C.3
Magrin, S.4
Mele, G.5
Mirto, S.6
-
26
-
-
0036369348
-
Prognosis of elderly patients with acute myelogenous leukemia: Analysis of 126 AML cases
-
Iwakiri R, Ohta M, Mikoshiba M, Tsutsumi H, Kumakawa T, Mori M. Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases. Int J Hematol. 2002;75: 45-50.
-
(2002)
Int J Hematol
, vol.75
, pp. 45-50
-
-
Iwakiri, R.1
Ohta, M.2
Mikoshiba, M.3
Tsutsumi, H.4
Kumakawa, T.5
Mori, M.6
-
27
-
-
54849436885
-
Prognositic factors in elderly patients with AML and the implications for treatment
-
Erba HP. Prognositic factors in elderly patients with AML and the implications for treatment. In: American Society of Hematology Education Program Book; 2007. p. 420-428.
-
(2007)
American Society of Hematology Education Program Book
, pp. 420-428
-
-
Erba, H.P.1
-
28
-
-
0028889993
-
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia
-
European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups
-
Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med. 1995;332:217-23.
-
(1995)
N Engl J Med
, vol.332
, pp. 217-223
-
-
Zittoun, R.A.1
Mandelli, F.2
Willemze, R.3
De Witte, T.4
Labar, B.5
Resegotti, L.6
-
29
-
-
0036036741
-
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial
-
Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JH, et al. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol. 2002;118: 385-400.
-
(2002)
Br J Haematol
, vol.118
, pp. 385-400
-
-
Burnett, A.K.1
Wheatley, K.2
Goldstone, A.H.3
Stevens, R.F.4
Hann, I.M.5
Rees, J.H.6
-
30
-
-
77950917665
-
Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: Results of the JALSG AML97 study
-
Sakamaki H, Miyawaki S, Ohtake S, Emi N, Yagasaki F, Mitani K, et al. Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study. Int J Hematol. 2010;91:284-92.
-
(2010)
Int J Hematol
, vol.91
, pp. 284-292
-
-
Sakamaki, H.1
Miyawaki, S.2
Ohtake, S.3
Emi, N.4
Yagasaki, F.5
Mitani, K.6
-
31
-
-
79952133594
-
A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: The JALSG AML201 Study
-
Miyawaki S, Ohtake S, Fujisawa S, Kiyoi H, Shinagawa K, Usui N, et al. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study. Blood. 2011;117:2366-72
-
(2011)
Blood
, vol.117
, pp. 2366-2372
-
-
Miyawaki, S.1
Ohtake, S.2
Fujisawa, S.3
Kiyoi, H.4
Shinagawa, K.5
Usui, N.6
|